CTLA-4 (dimer)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfe1/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfe1/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfe0/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfe0/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfdf/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfdf/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfde/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfde/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfdd/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfdd/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfdc/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfdc/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfdb/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfdb/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfda/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfda/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd9/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd9/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd7/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd7/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd6/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd6/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd5/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd5/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd4/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd4/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd3/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd3/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd2/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd2/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd1/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd1/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfd0/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfd0/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfcf/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfcf/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfce/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfce/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfcd/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfcd/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfcc/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfcc/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfcb/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfcb/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfca/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfca/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc9/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc9/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc8/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc8/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc7/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc7/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc6/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc6/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc5/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc5/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc4/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc4/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc3/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc3/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc2/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc2/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc1/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc1/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfc0/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfc0/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfbf/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfbf/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfbe/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfbe/ctla-4-dimer.png"},{"image":"https://icons.biorender.com/w75xh75/5f4fc4fc30380d0028b9bfbd/ctla-4-dimer.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5f4fc4fc30380d0028b9bfbd/ctla-4-dimer.png"}]
Keywords
immune checkpoint,t-cell,T cell,apc,dc89,cd86,CTLA4,CTLA-4,cytotoxic t-lymphocyte associated 4,ALPS4,CELIAC3,GRD4,GSE,IDDM12